Brian Anthony Kennedy - Net Worth and Insider Trading
Brian Anthony Kennedy Net Worth
The estimated net worth of Brian Anthony Kennedy is at least $43 Million dollars as of 2024-09-24. Brian Anthony Kennedy is the Director of Knight Therapeutics Inc and owns about 7,246,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $43 Million. Details can be seen in Brian Anthony Kennedy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Anthony Kennedy has not made any transactions after 2019-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Anthony Kennedy
Brian Anthony Kennedy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Anthony Kennedy owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Brian Anthony Kennedy’s form 4 insider trades.
Insider Ownership Summary of Brian Anthony Kennedy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | Director |
Brian Anthony Kennedy Latest Holdings Summary
Brian Anthony Kennedy currently owns a total of 1 stock. Brian Anthony Kennedy owns 7,246,000 shares of Knight Therapeutics Inc (TSX:GUD) as of July 25, 2019, with a value of $43 Million.
Latest Holdings of Brian Anthony Kennedy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | 7,246,000 | 5.91 | 42,823,860 |
Holding Weightings of Brian Anthony Kennedy
Brian Anthony Kennedy Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Anthony Kennedy has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 7,100,000 shares on July 25, 2019, which cost Brian Anthony Kennedy around $53 Million.
Insider Trading History of Brian Anthony Kennedy
- 1
Brian Anthony Kennedy Trading Performance
GuruFocus tracks the stock performance after each of Brian Anthony Kennedy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Anthony Kennedy is 13.29%. GuruFocus also compares Brian Anthony Kennedy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Anthony Kennedy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian Anthony Kennedy's insider trading performs compared to the benchmark.
Performance of Brian Anthony Kennedy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.09 | | | | | |
| Relative Return to S&P 500(%) | 8.3 | | | | | |
Brian Anthony Kennedy Ownership Network
Brian Anthony Kennedy Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Brian Anthony Kennedy is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Brian Anthony Kennedy made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Brian Anthony Kennedy Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Anthony Kennedy. Currently GuruFocus does not have mailing address information for Brian Anthony Kennedy.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
